Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Y. -H. | - |
dc.contributor.author | Lee, B. -W. | - |
dc.contributor.author | Chun, S. W. | - |
dc.contributor.author | Cha, B. S. | - |
dc.contributor.author | Lee, H. C. | - |
dc.date.accessioned | 2021-08-12T04:47:42Z | - |
dc.date.available | 2021-08-12T04:47:42Z | - |
dc.date.issued | 2011-10 | - |
dc.identifier.issn | 1368-5031 | - |
dc.identifier.issn | 1742-1241 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16185 | - |
dc.description.abstract | Aim: We investigated the clinical and metabolic parameters in type 2 diabetic patients who were inadequately controlled on sulfonylurea (SU) before initiating insulin therapy to characterise patients who are likely to achieve target glycaemic control with insulin analogues. Methods: A total of 120 Korean patients aged >= 40 years with insulin-naive, poorly controlled, SU-treated type 2 diabetes were randomised on the basis of SU dose, and obesity with 1 : 1 ratio of insulin detemir (long-acting analogue; LAA) and 70% insulin aspart protamine and 30% insulin aspart (biphasic insulin analogue; BIA). Patients who failed to reach <= 20% glycated albumin (GA) at 3 weeks were switched to therapy with a twice-daily BIA for 16 weeks. Results: Mean HbA(1c), GA, fasting and stimulated plasma glucose levels were significantly reduced after 16 weeks compared with the baseline in all groups, and 40% of patients reached the target HbA(1c) (<= 7%). Compared with responders, non-responders had significantly longer duration of diabetes and higher dose of glimepiride. However, there was no significant difference in insulin secretory profiles between responders and non-responders. Clinical factors such as diabetes duration, SU dose and BMI were independently associated with inadequate response to insulin analogues in patients with secondary failure. Conclusions: In type 2 diabetics with secondary SU failure, clinical parameters such as duration of diabetes (< 10 years), SU dose (<= 4 mg) and BMI should be taken into consideration as important factors than laboratory indices related to beta-cell function when predicting the response to insulin analogues. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Medicom International, Inc. | - |
dc.title | Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/j.1742-1241.2011.02755.x | - |
dc.identifier.scopusid | 2-s2.0-80053022273 | - |
dc.identifier.wosid | 000295039600010 | - |
dc.identifier.bibliographicCitation | International Journal of Clinical Practice, v.65, no.10, pp 1076 - 1084 | - |
dc.citation.title | International Journal of Clinical Practice | - |
dc.citation.volume | 65 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1076 | - |
dc.citation.endPage | 1084 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ORAL DISPOSITION INDEX | - |
dc.subject.keywordPlus | BETA-CELL FUNCTION | - |
dc.subject.keywordPlus | GLYCATED HEMOGLOBIN | - |
dc.subject.keywordPlus | SECONDARY FAILURE | - |
dc.subject.keywordPlus | DIABETIC-PATIENTS | - |
dc.subject.keywordPlus | TYPE-2 | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | ALBUMIN | - |
dc.subject.keywordPlus | GLUCOSE | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.